Your account is not claimed yet. You can sign up with ORCID to claim your account.

Kazuaki Matsumoto

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Venues

Pharmaceutics

Journal of fungi (Basel, Switzerland)

Antibiotics (Basel, Switzerland)

Clinical and translational science

Keio University Faculty of Pharmacy

Kumamoto Univarsity Faculty of Pharmaceutical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Keio University Faculty of Pharmacy Apr 1o 2017

Japan

Professor :: Division of Pharmacodynamics

Education History

Kumamoto Univarsity Faculty of Pharmaceutical Sciences Apr 1o 1994 - Mar 31o 2003

Japan

PHD :: Department of Biopharmaceutics

Publications

Kazutaka Oda, Tomoyuki Yamada, Kazuaki Matsumoto, Yuki Hanai, Takashi Ueda, Masaru Samura, Akari Shigemi, Hirofumi Jono, Hideyuki Saito, Toshimi Kimura
Model-informed precision dosing of teicoplanin for the rapid achievement of the target area under the concentration-time curve: A simulation study. Clinical and translational science (2023)
Kazutaka Oda, Tomoyuki Yamada, Kazuaki Matsumoto, Yuki Hanai, Takashi Ueda, Masaru Samura, Akari Shigemi, Hirofumi Jono, Hideyuki Saito, Toshimi Kimura
Model-informed precision dosing of vancomycin for rapid achievement of target area under the concentration-time curve: A simulation study. Clinical and translational science (2023)
Takashi Ueda, Yoshio Takesue, Kazuhiko Nakajima, Kaoru Ichiki, Kaori Ishikawa, Kumiko Yamada, Toshie Tsuchida, Naruhito Otani, Yoshiko Takahashi, Mika Ishihara, Shingo Takubo, Hiroki Ikeuchi, Motoi Uchino, Toshimi Kimura, Kazuaki Matsumoto, Kazutaka Oda, Takeshi Kimura
Validation of Vancomycin Area under the Concentration-Time Curve Estimation by the Bayesian Approach Using One-Point Samples for Predicting Clinical Outcomes in Patients with Methicillin-Resistant Staphylococcus aureus Infections. Antibiotics (Basel, Switzerland) 11 (1) (2022)
Yasuhiro Umezaki, Kazuaki Matsumoto, Kazuro Ikawa, Yuta Yokoyama, Yuki Enoki, Akari Shigemi, Erika Watanabe, Koyo Nakamura, Keiichiro Ueno, Hideyuki Terazono, Norifumi Morikawa, Yasuo Takeda
Concentration-Dependent Activity of Pazufloxacin against Pseudomonas aeruginosa : An In Vivo Pharmacokinetic/Pharmacodynamic Study. Antibiotics (Basel, Switzerland) 11 (7) (2022)
Masaru Samura, Yuki Kitahiro, Sho Tashiro, Hiromu Moriyama, Yuna Hamamura, Isamu Takahata, Rina Kawabe, Yuki Enoki, Kazuaki Taguchi, Yoshio Takesue, Kazuaki Matsumoto
Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant Staphylococcus &nbsp; aureus with Vancomycin Minimum Inhibitory Concentration > 1 µg/mL: A Systematic Review and Meta-Analysis. Pharmaceutics 14 (4) (2022)
Kengo Hanaya, Kaho Yamoto, Kazuaki Taguchi, Kazuaki Matsumoto, Shuhei Higashibayashi, Takeshi Sugai
Single-Step N-Terminal Modification of Proteins via a Bio-Inspired Copper(II)-Mediated Aldol Reaction. Chemistry (Weinheim an der Bergstrasse, Germany) 28 (47) (2022)
Kazuaki Matsumoto, Kazutaka Oda, Kensuke Shoji, Yuki Hanai, Yoshiko Takahashi, Satoshi Fujii, Yukihiro Hamada, Toshimi Kimura, Toshihiko Mayumi, Takashi Ueda, Kazuhiko Nakajima, Yoshio Takesue
Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. Pharmaceutics 14 (3) (2022)
Kazuaki Taguchi, Yuto Suzuki, Moeko Tsutsuura, Kana Hiraoka, Yuki Watabe, Yuki Enoki, Masaki Otagiri, Hiromi Sakai, Kazuaki Matsumoto
Liposomal Artificial Red Blood Cell-Based Carbon Monoxide Donor Is a Potent Renoprotectant against Cisplatin-Induced Acute Kidney Injury. Pharmaceutics 14 (1) (2021)
Yasutaka Sakamoto, Kazuhiro Kawabe, Tomoyo Suzuki, Kayoko Sano, Kazuo Ide, Tetsuta Nishigaki, Yuki Enoki, Kazuaki Taguchi, Hirofumi Koike, Hideaki Kato, Yukiko Sahashi, Kazuaki Matsumoto
Species Distribution of Candidemia and Their Susceptibility in a Single Japanese University Hospital: Prior Micafungin Use Affects the Appearance of Candida parapsilosis and Elevation of Micafungin MICs in Non-parapsilosis Candida Species. Journal of fungi (Basel, Switzerland) 7 (8) (2021)
Mizuki Moriyama, Xiaoxi Liu, Yuki Enoki, Kazuaki Matsumoto, Yoo Tanabe
Asymmetric Total Syntheses of Both Enantiomers of Plymuthipyranone B and Its Unnatural Analogues: Evaluation of anti-MRSA Activity and Its Chiral Discrimination. Pharmaceuticals (Basel, Switzerland) 14 (9) (2021)
Yasutaka Sakamoto, Hikaru Isono, Yuki Enoki, Kazuaki Taguchi, Takuya Miyazaki, Hiroyoshi Kunimoto, Hirofumi Koike, Maki Hagihara, Kenji Matsumoto, Hideaki Nakajima, Yukiko Sahashi, Kazuaki Matsumoto
Population Pharmacokinetic Analysis and Dosing Optimization of Prophylactic Fluconazole in Japanese Patients with Hematological Malignancy. Journal of fungi (Basel, Switzerland) 7 (11) (2021)
Sui Ouchi, Kazuaki Matsumoto, Maki Okubo, Yuta Yokoyama, Junko Kizu
Development of HPLC with fluorescent detection using NBD-F for the quantification of colistin sulfate in rat plasma and its pharmacokinetic applications. Biomedical chromatography : BMC 32 (5) (2018)

Kazuaki Matsumoto.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kazuaki Matsumoto